News | January 14, 2015

Opsens Announces First use of FFR Products in Europe

OptoWire and OptoMonitor guide therapy in patients with coronary heart disease

FFR catheters, Cath lab, OptoWire, OptoMonitor
Image courtesy of Opsens

January 14, 2015 — Opsens Inc. announced the first use of its Fractional Flow Reserve (FFR) products in Europe by the founders of FFR, namely Bernard De Bruyne, M.D. at the Cardiovascular Center Aalst, Belgium and by professor Nico Pijls, at the Catharina Hospital, Eindhoven the Netherlands. The OptoWire and OptoMonitor are Opsens’ products for FFR measurements to optimize the diagnosis and guide the therapy in patients with coronary heart disease.

"The arrival of an optical FFR guidewire such as the OptoWire on the market is positive for interventional cardiologists who need to obtain reliable FFR measurements. It allowed me to appreciate its zero drift performance during all cases performed while also acknowledging the constant connection reliability as well as its support during percutaneous coronary intervention", said Bernard De Bruyne, M.D., from the Cardiovascular Center Aalst.

The OptoWire provides intra-coronary blood pressure measurements with optical pressure guidewire technologies. It is immune to adverse effects related to blood contact, and allows easy connectivity that leads to reliable FFR measurements in extended conditions of usage. The product is designed to provide cardiologists with a guidewire delivering optimized performances to navigate coronary arteries and reach blockages. Based on industry sources, the FFR market represented more than $250 million in U.S. sales in 2013 and is expected to reach $1 billion in the medium-term.  

For more information: www.opsens.com

 

Related Content

News | Cath Lab

October 6, 2021 — Boston Scientific Corp. announced it entered into a definitive agreement to acquire Baylis Medical ...

Home October 06, 2021
Home
News | Cath Lab

September 21, 2021 — Medtronic is recalling its Pipeline Flex Embolization Device and Pipeline Flex Embolization Device ...

Home September 21, 2021
Home
Feature | Cath Lab | By Aaron Detate and Lars Thording

In the electrophysiology (EP) lab, hundreds of thousands of used devices are sent to reprocessors every year to get ...

Home September 14, 2021
Home
News | Cath Lab

July 22, 2021 — Medis Medical Imaging is partnering with CORRIB Core Lab and Sinomed in randomized clinical trial of ...

Home July 22, 2021
Home
News | Cath Lab

July 13, 2021 — East End Medical announced it received U.S. Food and Drug Administration (FDA) clearance for the company ...

Home July 14, 2021
Home
Feature | Cath Lab | By Dave Fornell, Editor

There is a trend in interventional cardiology that is now being called “renalism,” where patients with poor renal ...

Home May 14, 2021
Home
News | Cath Lab

May 12, 2021 — Abbott recently announced its new interventional imaging platform powered by Ultreon 1.0 Software, has ...

Home May 12, 2021
Home
Feature | Cath Lab | By Dave Fornell, Editor

April 29, 2021 — Here is the list of late-breaking study presentations and links to articles about each of them from the ...

Home May 06, 2021
Home
Videos | Cath Lab

Ashwin Nathan M.D., a cardiology fellow in the division of Cardiovascular Medicine at the Hospital of the University of ...

Home May 05, 2021
Home
News | Cath Lab

May 3, 2021 – Results from a new study find a broad range of patients who typically undergo revascularization for stable ...

Home May 03, 2021
Home
Subscribe Now